Zhejiang Jingxin Pharmaceutical Co., Ltd. (SHE:002020)

Market Cap	12.36B +12.4%
Revenue (ttm)	4.04B -0.4%
Net Income	759.89M +7.9%
EPS	0.92 +10.8%
Shares Out	813.76M
PE Ratio	16.52
Forward PE	16.18
Dividend	0.35 (2.30%)
Ex-Dividend Date	Jun 11, 2026

Volume	63,529,228
Open	12.43
Previous Close	14.66
Day's Range	12.43 - 15.47
52-Week Range	11.45 - 22.62
Beta	-0.11
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About SHE:002020

Zhejiang Jingxin Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products and medical devices in China and internationally. The company offers antihypertensive, antibiotics, quinolones, gastrointestinal promotion, antidiabetic, antiepileptic, antihistamine, H+ pump depressant, antihyper cholesterolemia, histamine H2 receptor blockader, antihyper cholesterolemirs, antidepressant, cephalosporin, and biopharma products; and API products, including ciprofloxacin, ciprofloxacin hydrochloride, ciprofloxacin lactat...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1990
• Employees: 3,732
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002020

Financial Performance

In 2025, SHE:002020's revenue was 4.07 billion, a decrease of -2.14% compared to the previous year's 4.16 billion. Earnings were 757.98 million, an increase of 6.46%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 3, 2026

Data Sources Report a data error